BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 24276246)

  • 1. Phosphatidylethanolamine-binding protein 4 is associated with breast cancer metastasis through Src-mediated Akt tyrosine phosphorylation.
    Li H; Huang F; Fan L; Jiang Y; Wang X; Li J; Wang Q; Pan H; Sun J; Cao X; Wang X
    Oncogene; 2014 Sep; 33(37):4589-98. PubMed ID: 24276246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of human phosphatidylethanolamine-binding protein 4 sensitizes breast cancer cells to tumor necrosis factor-alpha-induced apoptosis and cell growth arrest.
    Wang X; Li N; Li H; Liu B; Qiu J; Chen T; Cao X
    Clin Cancer Res; 2005 Oct; 11(20):7545-53. PubMed ID: 16243830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src.
    Liu H; Qiu J; Li N; Chen T; Cao X
    J Biol Chem; 2010 Jul; 285(29):21934-42. PubMed ID: 20460377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways.
    Zhou R; Xu L; Ye M; Liao M; Du H; Chen H
    Horm Metab Res; 2014 Oct; 46(11):753-60. PubMed ID: 24977660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Src activation with cardiotoxin III blocks migration and invasion of MDA-MB-231 cells.
    Tsai PC; Chu CL; Chiu CC; Chang LS; Lin SR
    Toxicon; 2013 Nov; 74():56-67. PubMed ID: 23933586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
    Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
    Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallic acid abolishes the EGFR/Src/Akt/Erk-mediated expression of matrix metalloproteinase-9 in MCF-7 breast cancer cells.
    Chen YJ; Lin KN; Jhang LM; Huang CH; Lee YC; Chang LS
    Chem Biol Interact; 2016 May; 252():131-40. PubMed ID: 27087131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
    Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
    Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
    Chun J; Kim YS
    Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MPPa-PDT suppresses breast tumor migration/invasion by inhibiting Akt-NF-κB-dependent MMP-9 expression via ROS.
    Huang L; Lin H; Chen Q; Yu L; Bai D
    BMC Cancer; 2019 Nov; 19(1):1159. PubMed ID: 31783821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
    Wang L; Wang X; Liang Y; Diao X; Chen Q
    Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morin, a flavonoid from Moraceae, suppresses growth and invasion of the highly metastatic breast cancer cell line MDA-MB‑231 partly through suppression of the Akt pathway.
    Jin H; Lee WS; Eun SY; Jung JH; Park HS; Kim G; Choi YH; Ryu CH; Jung JM; Hong SC; Shin SC; Kim HJ
    Int J Oncol; 2014 Oct; 45(4):1629-37. PubMed ID: 24993541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of cathepsin S and matrix metalloproteinase-9 via Src, a non-receptor tyrosine kinase, suppresses triple-negative breast cancer growth and metastasis.
    Gautam J; Banskota S; Lee H; Lee YJ; Jeon YH; Kim JA; Jeong BS
    Exp Mol Med; 2018 Sep; 50(9):1-14. PubMed ID: 30185799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesothelin promotes invasion and metastasis in breast cancer cells.
    Wang Y; Wang L; Li D; Wang HB; Chen QF
    J Int Med Res; 2012; 40(6):2109-16. PubMed ID: 23321167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frondoside A has an anti-invasive effect by inhibiting TPA-induced MMP-9 activation via NF-κB and AP-1 signaling in human breast cancer cells.
    Park SY; Kim YH; Kim Y; Lee SJ
    Int J Oncol; 2012 Sep; 41(3):933-40. PubMed ID: 22710811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation.
    Bai T; Luoh SW
    Carcinogenesis; 2008 Mar; 29(3):473-9. PubMed ID: 17916906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo.
    Jallal H; Valentino ML; Chen G; Boschelli F; Ali S; Rabbani SA
    Cancer Res; 2007 Feb; 67(4):1580-8. PubMed ID: 17308097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human phosphatidylethanolamine-binding protein 4 promoted the radioresistance of human rectal cancer by activating Akt in an ROS-dependent way.
    Qiu J; Yang G; Lin A; Shen Z; Wang D; Ding L
    PLoS One; 2014; 9(3):e90062. PubMed ID: 24594691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxyl-terminal modulator protein positively regulates Akt phosphorylation and acts as an oncogenic driver in breast cancer.
    Liu YP; Liao WC; Ger LP; Chen JC; Hsu TI; Lee YC; Chang HT; Chen YC; Jan YH; Lee KH; Zeng YH; Hsiao M; Lu PJ
    Cancer Res; 2013 Oct; 73(20):6194-205. PubMed ID: 23943800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.